1
|
Leroi I, Armitage CJ, Camacho EM, Charalambous AP, Connelly JP, Constantinidou F, David R, Dawes P, Elliott RA, Hann M, Holden A, Hooper E, Kennelly SP, Kontogianni E, Lawlor BA, Longobardi J, Paterson L, Politis AM, Reeves D, Schwimmer C, Thodi C, Worthington M, Yeung WK, Frison E. Hearing and vision rehabilitation for people with dementia in five European countries (SENSE-Cog): a randomised controlled trial. THE LANCET. HEALTHY LONGEVITY 2024:100625. [PMID: 39389083 DOI: 10.1016/j.lanhl.2024.07.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2024] [Revised: 07/17/2024] [Accepted: 07/19/2024] [Indexed: 10/12/2024] Open
Abstract
BACKGROUND The effect of hearing and vision difficulties on the risk of developing dementia and worsening outcomes in people already living with dementia is well established. We evaluated the clinical impact of a hearing and vision rehabilitation and support programme on quality of life in people with mild-to-moderate dementia and concurrent sensory difficulties. METHODS We conducted a parallel-group, multicentre, observer-blind, superiority randomised controlled trial in seven older adult clinics in five European countries (Cyprus, France, Greece, Ireland, and the UK). People with mild-to-moderate dementia with adult-acquired hearing difficulties, vision difficulties, or both were randomly assigned (1:1) along with their care partner to an 18-week home-basedsensory support intervention (SSI) of tailored hearing and vision rehabilitation and support, or to care as usual. Randomisation was blocked (block size of four, six, or eight) and stratified by country, with allocation assigned via a remote web-based system. The SSI included: full hearing assessment, vision assessment, or both; fitting of hearing aids, glasses, or other sensory aids; and home-based support from a sensory support therapist to assist adherence and uptake of sensory aids, foster social networking, and optimise the home sensory environment. Care as usual involved no additional intervention beyond services normally available to people with dementia at the respective sites. The primary outcome was health-related quality of life (Dementia Quality of Life Instrument [DEMQoL]) score at 36 weeks, reported as an adjusted mean difference. Analyses were done according to the intention-to-treat principle. This trial is registered with the ISRCTN Registry, ISRCTN17056211. FINDINGS Between May 4, 2018, and May 6, 2021, 252 people with mild-to-moderate dementia were randomly assigned, of whom 251 (n=126 in the SSI group and n=125 in the care as usual group) were included in the analysis. The mean age of participants was 79·6 years (SD 5·8), and 132 (53%) were women. After a median follow-up time of 37·7 weeks (IQR 36·2-39·0), the mean DEMQoL score was 92·8 (SD 15·2) in the SSI group and 92·8 (14·0) in the care as usual group (adjusted difference 0·18, 95% CI -2·13 to 2·30, p=0·87). Among 114 adverse events reported for 56 (44%) participants in the SSI group, ten events in nine participants were related or possibly related to the intervention (medical device pain or discomfort n=6, ear pain n=1, scratch to the ear n=1, sore eye n=1, redness n=1; all of grade 1). Serious adverse events were reported for 25 (20%) participants in the SSI group and 16 (13%) in the care as usual group. Six (5%) participants in the SSI group and five (4%) in the care as usual group died. None of the serious adverse events or deaths were related to the study intervention or procedures. INTERPRETATION This study showed no improvement in quality in life in participants who received the intervention in the longer term. Sensory difficulties are common in people with dementia and interventions aimed at improving sensory-cognitive health should be explored further. FUNDING EU Horizon 2020.
Collapse
Affiliation(s)
- Iracema Leroi
- Global Brain Health Institute and School of Medicine, Trinity College Dublin, Dublin, Ireland.
| | | | | | | | - J P Connelly
- Trinity College Dublin and Saint James's Hospital, Dublin, Ireland
| | - Fofi Constantinidou
- Centre for Applied Neuroscience and Department of Psychology, University of Cyprus, Nicosia, Cyprus
| | - Renaud David
- Nice University Hospital, Université Côte d'Azur, Nice, France; UR2CA-URRIS, Université Côte d'Azur, Nice, France
| | - Piers Dawes
- University of Manchester, Manchester, UK; University of Queensland Centre for Hearing Research (CHEAR), School of Health and Rehabilitation Sciences, University of Queensland, Brisbane, QLD, Australia
| | | | - Mark Hann
- University of Manchester, Manchester, UK
| | - Alison Holden
- Lancashire & South Cumbria NHS Foundation Trust, Preston, UK
| | | | - Sean P Kennelly
- Trinity Centre for Health Sciences, Tallaght Hospital, Dublin, Ireland
| | - Evangelia Kontogianni
- 1st Department of Psychiatry, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - Brian A Lawlor
- Global Brain Health Institute and School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - Julie Longobardi
- Université de Bordeaux, INSERM, Institut Bergonié, CHU Bordeaux, CIC1401-EC, Euclid/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France
| | | | - Antonis M Politis
- 1st Department of Psychiatry, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | | | - Christine Schwimmer
- Université de Bordeaux, INSERM, Institut Bergonié, CHU Bordeaux, CIC1401-EC, Euclid/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France
| | - Chryssoula Thodi
- Department of Health Sciences, European University Cyprus, Nicosia, Cyprus
| | | | | | - Eric Frison
- Université de Bordeaux, INSERM, Institut Bergonié, CHU Bordeaux, CIC1401-EC, Euclid/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France
| |
Collapse
|
2
|
Dawes P, Munro KJ. Hearing Loss and Dementia: Where to From Here? Ear Hear 2024; 45:529-536. [PMID: 38379156 PMCID: PMC11008448 DOI: 10.1097/aud.0000000000001494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Accepted: 01/29/2024] [Indexed: 02/22/2024]
Abstract
Victorian era psychologists were the first to comment on associations between sensory and cognitive function. More recently, hearing loss has been shown as a marker of risk for dementia. However, it is not known whether this association represents a causal impact of hearing loss, nor whether treating hearing loss may help prevent dementia. Most studies on relationships between hearing loss and cognitive outcomes are observational, are at risk of confounding, and cannot reach conclusions about causation. A recent high quality randomized controlled trial, relatively uncommon in audiology, reported no impact of a comprehensive hearing intervention in mitigating cognitive decline in older adults. Although secondary analysis revealed potential benefits in a sub-sample of adults, this finding may be spurious. Encouraging policymakers, patients, and other health care practitioners to address hearing loss in terms of dementia prevention may be inappropriate on the grounds of both relevance at individual level and lack of clear evidence of benefit. In addition, advocating need to address hearing loss in terms of mitigating dementia risk may reduce the importance of addressing hearing loss in its own right. Linking hearing loss to dementia risk may also exacerbate the stigma of hearing loss, inadvertently discouraging people from seeking help for hearing. We suggest that treating hearing loss may have important benefits in preventing or delaying diagnosis of dementia via improving orientation and functioning in daily life, without changing the underlying pathology. Rather than linking hearing loss to dementia risk, we suggest a positive message focusing on the known benefits of addressing hearing loss in terms of improved communication, quality of life, and healthy aging.
Collapse
Affiliation(s)
- Piers Dawes
- Centre for Hearing Research, School of Health and Rehabilitation Sciences, University of Queensland, Queensland, Australia
- Manchester Centre for Audiology and Deafness, University of Manchester, UK
| | - Kevin J. Munro
- Manchester Centre for Audiology and Deafness, University of Manchester, UK
| |
Collapse
|
3
|
Sheikh S, Tofique S, Zehra N, Amjad R, Rasheed M, Usman M, Lal S, Hooper E, Miah J, Husain N, Jafri H, Chaudhry N, Leroi I. SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia. Front Neurol 2021; 12:654143. [PMID: 34194381 PMCID: PMC8236518 DOI: 10.3389/fneur.2021.654143] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Accepted: 05/07/2021] [Indexed: 11/19/2022] Open
Abstract
Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to enhance quality of life in PwD for a LMIC setting, Pakistan. Design: This was a study in three phases: (1) training and capacity building to deliver the study, including Patient and Public Involvement (PPI); (2) cultural adaptation of the intervention; and (3) delivery of a single-group feasibility study with a pre-test post-test design. Setting: Home-based intervention, in two cities of Pakistan. Participants: Adults aged ≥ 60 with mild-moderate dementia and uncorrected or partially corrected hearing impairment, and their study partners (n = 14). Intervention: An adapted hearing support intervention (HSI) comprising a full assessment of hearing function, fitting of hearing aids, and home-based support from a “hearing support practitioner.” Outcomes: Ratings of the feasibility of the study procedures, and acceptability/tolerability of the adapted intervention were ascertained through questionnaires, participant diaries, therapist logbooks and semi-structured interviews. A signal of effectiveness of the intervention was also explored using a battery of dementia-related outcome measures. Results: Following cultural adaptation and capacity building for study conduct and delivery, we successfully implemented all intervention components in most participants, which were well-received and enacted by participant dyads. Acceptability (i.e., understanding, motivation, sense of achievement) and tolerability (i.e., effort, fatigue) ratings and safety of the intervention were within a priori target ranges. Recruitment and retention targets required improvement, due to the COVID-19 pandemic outbreak, as well as the lack of a clear clinical diagnostic pathway for dementia in both sites. Areas for future modification were clearly identified, including: the assessment/delivery logistics circuit; procedures for arranging visits; communication among referring clinicians and the study team. Conclusion: This is the first study in a LMIC of sensory enhancement to improve dementia outcomes. Positive feasibility, acceptability and tolerability findings suggest that a full-scale effectiveness trial, with certain modifications is warranted.
Collapse
Affiliation(s)
- Saima Sheikh
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Sehrish Tofique
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Nosheen Zehra
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Rabia Amjad
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Maham Rasheed
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Maria Usman
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Shanker Lal
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Emma Hooper
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom.,Department of Health, Institute of Health, University of Cumbria, Lancaster, United Kingdom
| | - Jahanara Miah
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Nusrat Husain
- Division of Global Mental Health, University of Manchester, Manchester, United Kingdom
| | - Hussain Jafri
- Department of Health, Alzheimer Pakistan, Lahore, Pakistan.,Department of Health, Fatima Jinnah Medical University, Lahore, Pakistan
| | - Nasim Chaudhry
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Iracema Leroi
- Department of Psychiatry, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
4
|
Leroi I, Wolski L, Charalambous AP, Constantinidou F, Renaud D, Dawes P, Hann M, Himmelsbach I, Miah J, Payne M, Simkin Z, Thodi C, Yeung WK, Yohannes AM. Support care needs of people with hearing and vision impairment in dementia: a European cross-national perspective. Disabil Rehabil 2021; 44:5069-5081. [PMID: 34027751 DOI: 10.1080/09638288.2021.1923071] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
PURPOSE Aging-related sensory impairments are among the most common and disabling comorbidities in people with dementia (PwD). This study explored the unmet support care needs (SCNs) from the perspectives of people with hearing and/or vision impairment in dementia (PwD), and their care partners in Europe. METHODS This was a two-phase mixed methods study. We administered standardized questionnaires of SCNs and quality of life (QoL) to PwD with hearing and/or vision impairment (n = 97), and their care partners (n = 97) in the UK, France, and Cyprus. Next, a purposive sub-sample of 34 participants (PwD and care partners) participated as focus groups (FGs) or semi-structured interviews to explore their SCNs in depth. RESULTS Over 94% of the participants reported unmet SCNs (median, 13 (range 5-23)). Nearly three-quarters reported SCNs in the moderate to high range, with the most prevalent unmet SCNs for PwD being in the psychological (>60%) and physical domains (>56%), followed by the need for health information (>46%). Emergent qualitative themes were: (1) the need for tailored support care interventions; (2) care burden, social isolation, and loneliness arising from the combined problems; (3) the need for adequate support from professionals from the different fields, including education around the use of sensory aids. Both study phases revealed that SCNs were highly individualized. CONCLUSIONS This cross-national study revealed that PwD with sensory impairment and their care partners experience a wide range of unmet SCNs, the interactions between sensory impairments, SCNs and QoL are also complex. A tailored intervention could address these unmet SCNs, including additional support with sensory aids, psychological support, more information about concurrent impairments, and joined up health systems providing care.Implications for rehabilitationA majority of participants with combined age-related hearing, vision, and cognitive impairment had unmet SCNs.The needs of care partners including the risk of loneliness and social isolation, need to be considered.Individually tailored, specific interventions for hearing, vision, and cognitive impairment should incorporate physical and psychological support, as well as education.
Collapse
Affiliation(s)
- Iracema Leroi
- Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.,Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
| | - Lucas Wolski
- Catholic University of Applied Sciences Freiburg, Freiburg, Germany
| | | | - Fofi Constantinidou
- Centre for Applied Neurosciences & Department of Psychology, University of Cyprus, Nicosia, Cyprus
| | - David Renaud
- CMRR Memory Center, Claude Pompidou Institute, University of Nice Sophia Antipolis, Nice, France
| | - Piers Dawes
- Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, UK
| | - Mark Hann
- Centre for Biostatistics, University of Manchester, Manchester, UK
| | - Ines Himmelsbach
- Catholic University of Applied Sciences Freiburg, Freiburg, Germany
| | - Jahanarah Miah
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
| | - Magali Payne
- CMRR Memory Center, Claude Pompidou Institute, University of Nice Sophia Antipolis, Nice, France
| | - Zoe Simkin
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
| | - Chryssoula Thodi
- Department of Health Sciences, European University Cyprus, Engomi, Cyprus
| | - Wai Kent Yeung
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
| | | |
Collapse
|
5
|
Kim JS, Lee HJ, Lee S, Lee HS, Jeong YJ, Son Y, Kim JM, Lee YJ, Park MH. Conductive Hearing Loss Aggravates Memory Decline in Alzheimer Model Mice. Front Neurosci 2020; 14:843. [PMID: 32903751 PMCID: PMC7438902 DOI: 10.3389/fnins.2020.00843] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 07/20/2020] [Indexed: 11/26/2022] Open
Abstract
The study of cognitive impairment associated with hearing loss has recently garnered considerable interest. Epidemiological data have demonstrated that hearing loss is a risk factor for cognitive decline as a result of aging. However, no previous study has examined the effect of hearing loss in patients with cognitive problems such as Alzheimer’s disease. Therefore, we investigated the effect of conductive hearing loss in an Alzheimer’s mouse model. Positron emission tomography (PET) and magnetic resonance imaging (MRI) were used to evaluate changes in glucose metabolism and gray matter concentrations in the 5xFAD Alzheimer’s Disease (AD) transgenic mouse model with and without conductive hearing loss (HL). Conductive hearing loss was induced using chronic perforation of the tympanic membrane. Behavioral data from the Y-maze and passive avoidance tests revealed greater memory deficits in the AD with HL (AD-HL) group than in the AD group. Following induction of hearing loss, lower cerebral glucose metabolism in the frontal association cortex was observed in the AD-HL group than in the AD group. Although lower glucose metabolism in the hippocampus and cerebellum was found in the AD-HL group than in the AD group at 3 months, the gray matter concentrations in these regions were not significantly different between the groups. Furthermore, the gray matter concentrations in the simple lobule, cingulate/retrosplenial cortex, substantia nigra, retrosigmoid nucleus, medial geniculate nucleus, and anterior pretectal nucleus at 7 months were significantly lower in the AD-HL group than in the AD group. Taken together, these results indicate that even partial hearing loss can aggravate memory impairment in Alzheimer’s disease.
Collapse
Affiliation(s)
- Jin Su Kim
- Division of RI Application, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.,Radiological and Medico-Oncological Sciences, University of Science and Technology, Seoul, South Korea
| | - Hae-June Lee
- Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea
| | - Seonhwa Lee
- Division of RI Application, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.,Department of Bio-Convergence Engineering, Korea University, Seoul, South Korea
| | - Ho Sun Lee
- Department of Otorhinolaryngology, Boramae Medical Center, Seoul Metropolitan Government-Seoul National University, Seoul, South Korea.,Department of Otorhinolaryngology, College of Medicine, Seoul National University, Seoul, South Korea
| | - Ye Ji Jeong
- Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea
| | - Yeonghoon Son
- Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.,National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, South Korea
| | - Jung Min Kim
- Department of Bio-Convergence Engineering, Korea University, Seoul, South Korea
| | - Yong Jin Lee
- Division of RI Application, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea
| | - Min-Hyun Park
- Department of Otorhinolaryngology, Boramae Medical Center, Seoul Metropolitan Government-Seoul National University, Seoul, South Korea.,Department of Otorhinolaryngology, College of Medicine, Seoul National University, Seoul, South Korea
| |
Collapse
|
6
|
Leroi I. "Losing my glasses…losing my mind": Perspectives on sensory impairment, loneliness, social isolation and dementia. Int J Geriatr Psychiatry 2020; 35:335-337. [PMID: 31943355 DOI: 10.1002/gps.5265] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/15/2020] [Indexed: 11/07/2022]
Affiliation(s)
- Iracema Leroi
- Global Brain Health Institute, School of Medicine, Trinity College Dublin, Dublin, Ireland
- University of Manchester, Manchester, UK
| |
Collapse
|
7
|
Leroi I, Simkin Z, Hooper E, Wolski L, Abrams H, Armitage CJ, Camacho E, Charalambous AP, Collin F, Constantinidou F, Dawes P, Elliott R, Falkingham S, Frison E, Hann M, Helmer C, Himmelsbach I, Hussain H, Marié S, Montecelo S, Thodi C, Yeung WK. Impact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field Trial. Int J Geriatr Psychiatry 2020; 35:348-357. [PMID: 31713262 PMCID: PMC7079053 DOI: 10.1002/gps.5231] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Accepted: 11/07/2019] [Indexed: 11/18/2022]
Abstract
OBJECTIVES Hearing, vision, and cognitive impairment commonly co-occur in older adults. Improving sensory function may positively impact outcomes in people with dementia (PwD). We developed a "sensory intervention" (SI) to support hearing and vision in PwD. Here, we report the findings of an international open-label field trial, and nested case series, to explore the impact of the SI on dementia-related outcomes. METHODS This was a home-based trial conducted in France, England, and Cyprus. Participants were people with mild-to-moderate dementia and hearing and/or vision impairment (n = 19) and their study partners (unpaid carers; n = 19). The "basic" SI included a hearing and vision assessment and provision of glasses and/or hearing aids. A subsample received the "extended" SI with additional weekly visits from a sensory support therapist (SST). Exploratory analyses of dementia-related, health utility and resource utilisation outcomes were performed. RESULTS Quality of life (QoL) and sensory functional ability improved. Change in QoL exceeded the threshold for a minimum clinically important difference. There was a modest improvement (in absolute terms) post intervention in behavioural disturbance, self-efficacy, and relationship satisfaction. Study partner time assisting instrumental activities of daily living (iADL) and supervision decreased by about 22 and 38 hours per month, respectively, although time for personal ADL support increased. Qualitative data supported effectiveness of the intervention: PwD were more socially engaged, less isolated, less dependent on study partners, and had improved functional ability and communication. CONCLUSIONS These findings support the need for a definitive randomised controlled trial (RCT) to evaluate the effectiveness of the intervention.
Collapse
Affiliation(s)
- Iracema Leroi
- Global Brain Health InstituteTrinity College DublinDublinIreland
- Division of Neuroscience and Experimental PsychologyUniversity of ManchesterManchesterUK
| | - Zoe Simkin
- Division of Neuroscience and Experimental PsychologyUniversity of ManchesterManchesterUK
| | - Emma Hooper
- Division of Neuroscience and Experimental PsychologyUniversity of ManchesterManchesterUK
| | - Lucas Wolski
- Institute of Applied Research, Development and Further EducationCatholic University of Applied Sciences FreiburgFreiburgGermany
| | - Harvey Abrams
- Department of Communication Sciences and DisordersUniversity of South FloridaTampaFL
| | | | - Elizabeth Camacho
- Manchester Centre for Health EconomicsUniversity of ManchesterManchesterUK
| | | | - Fideline Collin
- INSERM, EUCLID/F‐CRIN Clinical Trials PlatformUniversity of BordeauxTalenceAquitaineFrance
| | | | - Piers Dawes
- Manchester Centre for Audiology and DeafnessUniversity of ManchesterManchesterUK
| | - Rachel Elliott
- Manchester Centre for Health EconomicsUniversity of ManchesterManchesterUK
| | - Sue Falkingham
- Department of AudiologyStarkey Hearing TechnologiesStockportUK
| | - Eric Frison
- INSERM, EUCLID/F‐CRIN Clinical Trials PlatformUniversity of BordeauxTalenceAquitaineFrance
| | - Mark Hann
- Centre for BiostatisticsUniversity of ManchesterManchesterUK
| | - Catherine Helmer
- INSERM, Bordeaux Population Health Research Center, Team LEHAUniversity of BordeauxTalenceAquitaineFrance
| | - Ines Himmelsbach
- Institute of Applied Research, Development and Further EducationCatholic University of Applied Sciences FreiburgFreiburgGermany
| | - Hannah Hussain
- Manchester Centre for Health EconomicsUniversity of ManchesterManchesterUK
| | - Sarah Marié
- Research and DevelopmentEssilor InternationalParisFrance
| | | | - Chryssoula Thodi
- Department of Health SciencesEuropean University CyprusNicosiaCyprus
| | - Wai Kent Yeung
- Division of Neuroscience and Experimental PsychologyUniversity of ManchesterManchesterUK
| |
Collapse
|
8
|
Leroi I, Armitage CJ, Collin F, Frison E, Hann M, Hooper E, Reeves D, Simkin Z, Wolski L. A randomised controlled trial of hearing and vision support in dementia: Protocol for a process evaluation in the SENSE-Cog trial. Trials 2020; 21:223. [PMID: 32093757 PMCID: PMC7041097 DOI: 10.1186/s13063-020-4135-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Accepted: 02/03/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Optimising hearing and vision function may be important in improving a range of outcomes for people living with dementia (PwD) and their companions. The SENSE-Cog cross-national randomised controlled trial (RCT) is evaluating the effectiveness of a sensory intervention (SI) to improve quality of life for PwD with concurrent hearing and/or vision impairment, in five European countries. To ascertain how or why the intervention will, or will not, achieve its outcomes, we have designed a process evaluation to explore potential discrepancies between expected and observed outcomes. This will also help us to understand how context may influence the outcomes. Here we describe the protocol for this process evaluation, which is embedded within the RCT. METHODS/DESIGN We will use a mixed methods approach with a theoretical framework derived from the UK Medical Research Council's' guidance on process evaluations. It will include the following: (1) evaluating how key aspects of the intervention will be delivered, which will be important to scale the intervention in real world populations; (2) characterising the contextual issues, which may shape the delivery and the impact of the intervention in different countries; and (3) investigating possible causal mechanisms through analyses of potential moderators and mediators. To avoid bias, we will analyse the process data before the analysis of the main effectiveness outcomes. DISCUSSION This evaluation will provide insight into how the complex SENSE-Cog SI will be tailored, enacted and received across the different European contexts, all of which have unique health and social care economies. The findings will provide insight into the causal mechanisms effecting change, and will determine whether we should implement the intervention, if effective, on a wider scale for PwD and concurrent sensory impairment. TRIAL REGISTRATION ISRCTN, ISRCTN17056211. Registered on 19 February 2018.
Collapse
Affiliation(s)
- Iracema Leroi
- Global Brain Health Institute, School of Medicine, Trinity College Dublin, Trinity College Institute of Neurosciences, Room 0.60, Lloyd Building, Dublin 2, Ireland
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| | - Christopher J. Armitage
- Manchester Centre for Health Psychology, School of Psychological Sciences, University of Manchester, Manchester, UK
| | - Fidéline Collin
- Bordeaux Population Health Center, Univ. Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, CHU Bordeaux, F-33000 Bordeaux, France
| | - Eric Frison
- Bordeaux Population Health Center, Univ. Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, CHU Bordeaux, F-33000 Bordeaux, France
| | - Mark Hann
- Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, UK
| | - Emma Hooper
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| | - David Reeves
- Division of Population Health, Health Services Research & Primary Care, University of Manchester, Manchester, UK
| | - Zoe Simkin
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| | - Lucas Wolski
- Institute of Applied Research, Development and Continuing Education, Catholic University of Applied Sciences, Freiburg, Germany
| |
Collapse
|
9
|
Wolski L, Leroi I, Regan J, Dawes P, Charalambous AP, Thodi C, Prokopiou J, Villeneuve R, Helmer C, Yohannes AM, Himmelsbach I. The need for improved cognitive, hearing and vision assessments for older people with cognitive impairment: a qualitative study. BMC Geriatr 2019; 19:328. [PMID: 31791251 PMCID: PMC6889573 DOI: 10.1186/s12877-019-1336-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Accepted: 10/31/2019] [Indexed: 12/01/2022] Open
Abstract
Background Hearing and vision (sensory) impairments are highly prevalent in people with dementia (PwD) and exacerbate the impact of living with dementia. Assessment of sensory or cognitive function may be difficult if people have concurrent dual or triple impairments. Most standard cognitive assessment tests are heavily dependent on having intact hearing and vision, and impairments in these domains may render the assessments unreliable or even invalid. Likewise, dementia may impede on the accurate reporting of symptoms that is required for most hearing and vision assessments. Thus, there is an urgent need for hearing, vision and cognitive assessment strategies to be adapted to ensure that appropriate management and support can be provided. Objective To explore the perspectives of PwD and the care partners regarding the need for accurate hearing, vision and cognitive assessments. Methods We conducted focus groups and semi-structured interviews regarding the clinical assessment for cognitive, hearing and visual impairment. Participants (n = 18) were older adults with mild to moderate dementia and a sensory impairment as well as their care partners (e.g. a family member) (n = 15) at three European sites. The qualitative material was analysed according to Mayring’s summative content analysis approach. Results Participants reported that hearing, vision and cognitive assessments were not appropriate to the complex needs of PwD and sensory comorbidity and that challenges in communication with professionals and conveying unmet needs and concerns by PwD were common in all three types of clinical assessments. They felt that information about and guidance regarding support for the condition was not adequate in the assessments and that information sharing among the professionals regarding the concurrent problems was limited. Professionals were reported as being concerned only with problems related to their own discipline and had limited regard for problems in other domains which might impact on their own assessments. Conclusions The optimal assessment and support for PwD with multiple impairments, more comprehensive, yet easy to understand, information regarding these linked to conditions and corrective device use is needed. Communication among health care professionals relevant to hearing, vision and cognition needs to be improved.
Collapse
Affiliation(s)
- Lucas Wolski
- Institute for Applied Sciences, Catholic University of Applied Sciences Freiburg, Freiburg im Breisgau, Germany.
| | - Iracema Leroi
- Global Brain Health Institute, School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - Jemma Regan
- Devon Partnership NHS Trust, Wonford House, Exeter, UK
| | - Piers Dawes
- The Department of Linguistics, Macquarie University, Sydney, Australia.,Manchester Centre for Health Psychology, School of Psychological Sciences, Univesity of Manchester, Manchester, UK
| | | | - Chryssoula Thodi
- Department of Health Sciences, European University of Cyprus, Nicosia, Cyprus
| | | | | | | | | | - Ines Himmelsbach
- Institute for Applied Sciences, Catholic University of Applied Sciences Freiburg, Freiburg im Breisgau, Germany
| |
Collapse
|
10
|
Field B, Mountain G, Burgess J, Di Bona L, Kelleher D, Mundy J, Wenborn J. Recruiting hard to reach populations to studies: breaking the silence: an example from a study that recruited people with dementia. BMJ Open 2019; 9:e030829. [PMID: 31748295 PMCID: PMC6886904 DOI: 10.1136/bmjopen-2019-030829] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE To share the challenges of recruiting people with dementia to studies, using experiences from one recently completed trial as an exemplar. BACKGROUND Research publications always cite participant numbers but the effort expended to achieve the sample size is rarely reported, even when the study involved recruiting a hard to reach population. A multisite study of a psychosocial intervention for people with dementia illustrates the challenges. This study recruited 468 'dyads' (a person with dementia and a family carer together) from 15 sites but the time taken to achieve this was longer than originally estimated. This led to a study extension and the need for additional sites. Recruitment data revealed that certain sites were more successful than others, but why? Can the knowledge gained be used to inform other studies? METHODS Secondary analysis of routinely collected recruitment data from three purposefully selected sites was examined to understand the strategies used and identify successful approaches. FINDINGS At all three sites, the pool of potential recruits funnelled to a few participants. It took two sites 18 months longer than the third to achieve recruitment numbers despite additional efforts. Explanations given by potential participants for declining to take part included ill health, reporting they were 'managing', time constraints, adjusting to a diagnosis of dementia and burden of study procedures. CONCLUSIONS Successful recruitment of people with dementia to studies, as one example of a hard to reach group, requires multiple strategies and close working between researchers and clinical services. It requires a detailed understanding of the needs and perspectives of the specific population and knowledge about how individuals can be supported to participate in research. Experiences of recruitment should be disseminated so that knowledge generated can be used to inform the planning and implementation of future research studies.
Collapse
Affiliation(s)
- Becky Field
- School of Health and Related Research, Faculty of Medicine Dentistry and Health, University of Sheffield, Sheffield, UK
| | - Gail Mountain
- School of Health and Related Research, Faculty of Medicine Dentistry and Health, University of Sheffield, Sheffield, UK
- Centre for Applied Dementia Studies, University of Bradford, Bradford, West Yorkshire, UK
| | - Jane Burgess
- Research and Development Department, North East London NHS Foundation Trust Goodmayes Hospital, Ilford, Essex, UK
| | - Laura Di Bona
- School of Health and Related Research, Faculty of Medicine Dentistry and Health, University of Sheffield, Sheffield, UK
- Engagement and Experience Team, Sheffield Health and Social Care NHS Foundation Trust, Sheffield, Sheffield, UK
| | - Daniel Kelleher
- Research and Development Department, Humber Teaching NHS Foundation Trust, Willerby, UK
| | - Jacqueline Mundy
- Engagement and Experience Team, Sheffield Health and Social Care NHS Foundation Trust, Sheffield, Sheffield, UK
| | - Jennifer Wenborn
- Research and Development Department, North East London NHS Foundation Trust Goodmayes Hospital, Ilford, Essex, UK
- Division of Psychiatry, University College London, London, London, UK
| |
Collapse
|
11
|
Leroi I, Himmelsbach I, Wolski L, Littlejohn J, Jury F, Parker A, Charalambous AP, Dawes P, Constantinidou F, Thodi C. Assessing and managing concurrent hearing, vision and cognitive impairments in older people: an international perspective from healthcare professionals. Age Ageing 2019; 48:580-587. [PMID: 30608511 PMCID: PMC6593321 DOI: 10.1093/ageing/afy183] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Revised: 08/16/2018] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND there is a significant gap in the understanding, assessment and management of people with dementia and concurrent hearing and vision impairments. OBJECTIVE from the perspective of professionals in dementia, hearing and vision care, we aimed to: (1) explore the perceptions of gaps in assessment and service provision in ageing-related hearing, vision and cognitive impairment; (2) consider potential solutions regarding this overlap and (3) ascertain the attitudes, awareness and practice, with a view to implementing change. METHODS our two-part investigation with hearing, vision, and dementia care professionals involved: (1) an in-depth, interdisciplinary, international Expert Reference Group (ERG; n = 17) and (2) a wide-scale knowledge, attitudes and practice survey (n = 653). The ERG involved consensus discussions around prototypic clinical vignettes drawn from a memory centre, an audiology clinic, and an optometry clinic, analysed using an applied content approach. RESULTS the ERG revealed several gaps in assessment and service provision, including a lack of validated assessment tools for concurrent impairments, poor interdisciplinary communication and care pathways, and a lack of evidence-based interventions. Consensus centred on the need for flexible, individualised, patient-centred solutions, using an interdisciplinary approach. The survey data validated these findings, highlighting the need for clear guidelines for assessing and managing concurrent impairments. CONCLUSIONS this is the first international study exploring professionals' views of the assessment and care of individuals with age-related hearing, vision and hearing impairment. The findings will inform the adaptation of assessments, the development of supportive interventions, and the new provision of services.
Collapse
Affiliation(s)
- Iracema Leroi
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
| | - Ines Himmelsbach
- Institute of Applied Research, Development and Further Education, Catholic University of Freiburg, Freiburg, Germany
| | - Lucas Wolski
- Institute of Applied Research, Development and Further Education, Catholic University of Freiburg, Freiburg, Germany
| | - Jenna Littlejohn
- Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, UK
| | - Francine Jury
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
| | - Angela Parker
- Greater Manchester NIHR Clinical Research Network, Manchester University NHS Foundation Trust, 2nd Floor City Labs, Nelson Steer, Manchester, UK
| | - Anna Pavlina Charalambous
- Department of Health Sciences, School of Sciences, European University Cyprus, 6 Diogenes Str, Nicosia, Cyprus
| | - Piers Dawes
- Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, UK
| | - Fofi Constantinidou
- Department of Psychology & Center for Applied Neuroscience, University of Cyprus, Kallipoleos 75, Nicosia, Cyprus
| | - Chryssoula Thodi
- Department of Health Sciences, School of Sciences, European University Cyprus, 6 Diogenes Str, Nicosia, Cyprus
| | | |
Collapse
|
12
|
Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous AP, Collin F, Constantinidou F, Dawes P, Elliott R, Falkingham S, Frison E, Hann M, Helmer C, Himmelsbach I, Hussain H, Marié S, Montecelo S, Reeves D, Regan J, Thodi C, Wolski L, Leroi I. Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial. J Am Geriatr Soc 2019; 67:1472-1477. [PMID: 31034588 DOI: 10.1111/jgs.15936] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 03/27/2019] [Accepted: 03/27/2019] [Indexed: 11/28/2022]
Abstract
OBJECTIVES People with dementia (PwD) frequently experience hearing and vision impairment that is underrecognized and undertreated, resulting in reduced quality of life. Managing these impairments may be an important strategy to improve outcomes in PwD. Our objective was to field-trial a multifaceted sensory intervention (SI) to enhance hearing and vision in PwD. DESIGN An international single-arm open-label feasibility, acceptability, and tolerability study. SETTING Home-based setting in the United Kingdom, France, and Cyprus. PARTICIPANTS Adults aged 60 years and older with mild-to-moderate dementia and uncorrected or suboptimally corrected hearing and/or vision impairment, and their study partners (n = 19 dyads). INTERVENTION A sensory intervention (SI), comprising assessment of hearing and vision, fitting of corrective devices (glasses, hearing aids), and home-based support from a sensory support therapist for device adherence and maintenance, communication training, referral to support services, environmental sensory modification, and optimization of social inclusion. MEASUREMENTS Ratings of study procedure feasibility, and intervention acceptability/tolerability, ascertained through questionnaires, participant diaries, therapist logbooks, and semistructured interviews. RESULTS We successfully delivered all intervention components, and these were received and enacted as intended in all those who completed the intervention. No serious adverse events were reported. Acceptability (ie, understanding, motivation, sense of achievement) and tolerability (ie, effort, fatigue) ratings of the intervention were within a priori target ranges. We met recruitment and retention (93.8%) targets in two of the three sites. Participants completed more than 95% of diary entries, representing minimal missing data. Delays in the logistics circuit for the assessment and delivery of hearing aids and glasses were identified, requiring modification. The need for minor modifications to some outcome measures and the inclusion criteria were identified. CONCLUSION This is the first study combining home-based hearing and vision remediation in PwD. The positive feasibility, acceptability, and tolerability findings suggest that a full-scale efficacy trial, with certain modifications, is achievable.
Collapse
Affiliation(s)
- Emma Hooper
- Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Zoe Simkin
- Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | | | - Elizabeth Camacho
- Manchester Centre for Health Economics, School of Health Sciences, University of Manchester, Manchester, United Kingdom
| | | | - Fideline Collin
- INSERM, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux Population Health Center, CHU Bordeaux, F-33000, University of Bordeaux, Bordeaux, France
| | - Fofi Constantinidou
- Department of Psychology and Center for Applied Neuroscience, University of Cyprus, Nicosia, Cyprus
| | - Piers Dawes
- Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, United Kingdom
| | - Rachel Elliott
- Manchester Centre for Health Economics, School of Health Sciences, University of Manchester, Manchester, United Kingdom
| | | | - Eric Frison
- INSERM, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux Population Health Center, CHU Bordeaux, F-33000, University of Bordeaux, Bordeaux, France
| | - Mark Hann
- Centre for Biostatistics, University of Manchester, Manchester, United Kingdom
| | - Catherine Helmer
- INSERM, Bordeaux Population Health Research Center, Team LEHA, University of Bordeaux, Bordeaux, France
| | - Ines Himmelsbach
- Catholic University of Applied Sciences Freiburg, Freiburg, Germany
| | - Hannah Hussain
- Manchester Centre for Health Economics, School of Health Sciences, University of Manchester, Manchester, United Kingdom
| | - Sarah Marié
- Essilor International, Research & Development, Paris, France
| | | | - David Reeves
- Centre for Biostatistics, University of Manchester, Manchester, United Kingdom
| | - Jemma Regan
- University of Manchester, Manchester, United Kingdom
| | - Chryssoula Thodi
- Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus
| | - Lucas Wolski
- Catholic University of Applied Sciences Freiburg, Freiburg, Germany
| | - Iracema Leroi
- Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom.,Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.,Greater Manchester Mental Health Foundation Trust, Manchester, United Kingdom
| |
Collapse
|
13
|
Interventions for hearing and vision impairment to improve outcomes for people with dementia: a scoping review. Int Psychogeriatr 2019; 31:203-221. [PMID: 30244688 DOI: 10.1017/s1041610218000728] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
UNLABELLED ABSTRACTBackground:Age-related hearing and vision problems are common among people with dementia and are associated with poorer function, reduced quality of life and increased caregiver burden. Addressing sensory impairments may offer an opportunity to improve various aspects of life for people with dementia. METHODS Electronic databases were searched using key terms dementia, hearing impairment, vision impairment, intervention, and management. Database searches were supplemented by hand searching bibliographies of papers and via consultation with a network of health professional experts. Studies were eligible for inclusion if they included adults aged over 50 with dementia with adult-onset hearing or vision impairment who had received a hearing or vision intervention in relation to cognitive function, rate of decline, psychiatric symptoms, hearing/vision-related disability, quality of life, and/or caregiver burden outcomes. A range of study designs were included. Results were summarized descriptively according to level of evidence and effect sizes calculated where possible. Risk of bias was assessed using Downs and Black's (1998) checklist. The development of the intervention was summarized according to the CReDECI2 scheme. PROSPERO review registration number 2016:CRD42016039737. RESULTS Twelve papers describing hearing interventions and five papers describing vision interventions were included. Most were of low to moderate quality. One high quality randomized controlled trial of a hearing aid intervention was identified. Hearing interventions included provision of hearing aids, assistive listening devices, communication strategies, hearing aid trouble shooting, and cochlear implantation. Vision interventions included prism lenses, rehabilitation training, and cataract surgery. There was no consistent evidence for the positive impact of hearing/vision interventions on cognitive function, rate of cognitive decline, quality of life, or caregiver burden. CONCLUSION Sensory interventions may promote better outcomes, but there is a need for properly powered, controlled trials of hearing and vision interventions on outcomes relevant to people living with dementia.
Collapse
|
14
|
Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I. Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial. Trials 2019; 20:80. [PMID: 30683150 PMCID: PMC6347775 DOI: 10.1186/s13063-018-2973-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2018] [Accepted: 10/09/2018] [Indexed: 01/21/2023] Open
Abstract
BACKGROUND Hearing and vision impairments are highly prevalent in people with dementia and may have a negative impact on quality of life and other dementia-related outcomes. Intervening to optimise sensory impairment and support sensory function may be a means of improving dementia-related outcomes. The SENSE-Cog trial will test whether a home-based multi-part sensory intervention is effective in improving quality of life and other key outcomes in people with dementia and hearing or vision problems (or both) and their companions. METHODS This is an European, multi-centre, observer-blind, pragmatic, randomised controlled trial. Three hundred fifty four people with dementia and hearing or vision impairment (or both) and their companions will be randomly assigned to receive either "care as usual" or a multi-component sensory intervention including assessment and correction of hearing or vision impairments (or both), home-based (maximum 10 visits over 18 weeks), therapist-delivered sensory support (that is, adherence to devices; improving the sensory environment (that is, lighting), communication training, and sign-posting to other support agencies). Change from baseline to intervention end (18 weeks) and post-intervention (36 weeks) will be compared between the two arms in the following outcomes: quality of life (primary endpoint), sensory and cognitive functional ability, relationships, mental well-being, health resource utilisation and cost-effectiveness. DISCUSSION This is one of two articles outlining the SENSE-Cog trial. Here, we describe the protocol for the effectiveness of the SENSE-Cog intervention. A parallel and complementary process evaluation will be described elsewhere. If the SENSE-Cog trial demonstrates that the sensory intervention improves outcomes in dementia, we will make a toolkit of training materials, resources and information available to health and social care providers to implement the intervention in routine practice. This will be a significant contribution to the therapeutic management of people with dementia and sensory impairment. TRIAL REGISTRATION ISRCTN (Trial ID: ISRCTN17056211 ) on 19 February 2018.
Collapse
Affiliation(s)
- Jemma Regan
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PL UK
| | - Eric Frison
- University of Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux Population Health Center, CHU Bordeaux, F-33000 Bordeaux, France
| | - Fidéline Collin
- University of Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux Population Health Center, CHU Bordeaux, F-33000 Bordeaux, France
| | - Piers Dawes
- Manchester Centre for Audiology and Deafness (ManCAD) University of Manchester and the Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PL UK
| | - Mark Hann
- Division of Population Health, Health Services Research & Primary Care, University of Manchester, Grafton Street, Manchester, M12 9NT UK
| | - Ines Himmelsbach
- Institute of Applied Research, Development and Continuing Education, Catholic University of Applied Sciences, Karlstraße 63, Freiburg, 79104 Germany
| | - Emma Hooper
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PL UK
| | - David Reeves
- Division of Population Health, Health Services Research & Primary Care, University of Manchester, Grafton Street, Manchester, M12 9NT UK
| | - Zoe Simkin
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PL UK
| | - Chryssoula Thodi
- School of Sciences, Department of Health Sciences, European University Cyprus, Diogenis Street, Nicosia, 2404 Cyprus
| | - Fan Yang
- Division of Population Health, Health Services Research & Primary Care, University of Manchester, Grafton Street, Manchester, M12 9NT UK
| | - Iracema Leroi
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Oxford Road, Manchester, M13 9PL UK
| |
Collapse
|
15
|
Regan J, Dawes P, Pye A, Armitage CJ, Hann M, Himmelsbach I, Reeves D, Simkin Z, Yang F, Leroi I. Improving hearing and vision in dementia: protocol for a field trial of a new intervention. BMJ Open 2017; 7:e018744. [PMID: 29187416 PMCID: PMC5719288 DOI: 10.1136/bmjopen-2017-018744] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
INTRODUCTION Quality of life and other key outcomes may be improved by optimising hearing and vision function in people living with dementia. To date, there is limited research assessing the efficacy of interventions aimed at improving hearing and vision in people with dementia. Here, we outline a protocol to field test a newly developed home-based intervention, designed to optimise sensory functioning in people with dementia in three European sites. The results of this study will inform the design and conduct of a full-scale randomised controlled trial (RCT) in five European sites. METHODS AND ANALYSIS In this multisite, single arm, open label, feasibility study, participants with dementia (n=24) will be assessed for hearing and vision impairments and be prescribed a hearing aid and/or glasses. Each participant will have a study partner ('dyads'). A subset of dyads will receive 'sensory support' from a 'sensory support therapist', comprising home visits over 12 weeks. The therapist will offer the following intervention: adherence support for corrective devices; adaptations to the home environment to facilitate sensory function; communication training; and referral to community-based support services. The primary outcomes will be process measures assessing the feasibility, tolerability and acceptability of: (1) the intervention components; (2) the method of implementation of the intervention and (3) the study procedures, including outcome assessment measures. Quantitative data will be collected at baseline and follow-up. Qualitative data using semistructured interviews will be collected postintervention and weekly, using participant diaries. Finally, we will explore a model of cost-effectiveness to apply in the subsequent full-scale trial. This feasibility study is a necessary step in the development of a complex, individualised, psychosocial intervention. The data gathered will allow logistical and theoretical processes to be refined in preparation for a full-scale RCT. ETHICS AND DISSEMINATION Ethical approval was obtained in all three participating countries. Results of the field trial will be submitted for publication in a peer-reviewed journal.
Collapse
Affiliation(s)
- Jemma Regan
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| | - Piers Dawes
- Manchester Centre for Audiology and Deafness (ManCAD), University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, U.K
| | - Annie Pye
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| | - Christopher J Armitage
- Manchester Centre for Health Psychology, School of Psychological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
| | - Mark Hann
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Manchester Centre for Health Economics, University of Manchester, Manchester, UK
| | - Ines Himmelsbach
- Institute of Applied Research, Development and Continuing Education, Catholic University of Applied Sciences, Freiburg, Germany
| | - David Reeves
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Manchester Centre for Health Economics, University of Manchester, Manchester, UK
| | - Zoe Simkin
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| | - Fan Yang
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Manchester Centre for Health Economics, University of Manchester, Manchester, UK
| | - Iracema Leroi
- Division of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences Centre, Manchester, UK
| |
Collapse
|